Ischaemic preconditioning: can the protection be bottled?
Cohen
M V
MV
Department of Physiology, University of South Alabama, Mobile.
Downey
J M
JM
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D017202:Myocardial Ischemia / Q000378:metabolism* / Q000503:physiopathology; D015425:Myocardial Reperfusion; D009638:Norepinephrine / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D011983:Receptors, Purinergic / Q000187:drug effects; D013552:Swine; D013997:Time Factors
D000316:Adrenergic alpha-Agonists; D011983:Receptors, Purinergic; D002217:Carbachol; D011493:Protein Kinase C; D009638:Norepinephrine